BAS - BASF SE
XETRA
->
Basic Materials
->
Chemicals
Ludwigshafen am Rhein,
Germany
Type: Equity
BAS price evolution
BAS
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $3183 | $3780 | $4494 | $2624 |
| Short term investments | $202 | $207 | $209 | $208 |
| Net receivables | $21910 | $23158 | $22270 | $14282 |
| Inventory | $17140 | $15986 | $14847 | $13868 |
| Total current assets | $42435 | $43351 | $42726 | $35051 |
| Long term investments | $13915 | $14347 | $11537 | $12958 |
| Property, plant & equipment | $22969 | $22254 | $21779 | $17871 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $97030 | $96972 | $93983 | $87383 |
| Current liabilities | ||||
| Accounts payable | $8595 | $9068 | $8987 | $7826 |
| Deferred revenue | ||||
| Short long term debt | $6621 | $5791 | $5939 | $3677 |
| Total current liabilities | $24714 | $26633 | $25093 | $20081 |
| Long term debt | $15707 | $15639 | $15015 | $13799 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $47930 | $50599 | $51428 | $45302 |
| Shareholders' equity | ||||
| Retained earnings | $40205 | $39529 | $40767 | $40365 |
| Other shareholder equity | $6226 | $4242 | -$803 | -$749 |
| Total shareholder equity | $47607 | $44947 | $41140 | $40792 |
| (in millions $) | 30 Dec 2021 | 30 Dec 2020 | 30 Dec 2019 | 30 Dec 2018 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2624 | $4330 | $2427 | $2300 |
| Short term investments | $208 | $207 | $444 | $344 |
| Net receivables | $14282 | $11181 | $10664 | $12106 |
| Inventory | $13868 | $10010 | $11223 | $12166 |
| Total current assets | $35051 | $29868 | $30990 | $43221 |
| Long term investments | $12958 | $13334 | $15644 | $2773 |
| Property, plant & equipment | $17871 | $16660 | $18944 | $20780 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $87383 | $80292 | $86950 | $86556 |
| Current liabilities | ||||
| Accounts payable | $7826 | $5291 | $5087 | $5122 |
| Deferred revenue | ||||
| Short long term debt | $3677 | $2688 | $3035 | $3347 |
| Total current liabilities | $20081 | $16280 | $16604 | $23329 |
| Long term debt | $13799 | $15856 | $15065 | $15407 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $45302 | $45894 | $44600 | $50447 |
| Shareholders' equity | ||||
| Retained earnings | $40365 | $37911 | $42056 | $36699 |
| Other shareholder equity | -$749 | -$5359 | -$1735 | -$2821 |
| Total shareholder equity | $40792 | $33728 | $41497 | $35054 |
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $21946 | $22974 | $23083 | $19776 |
| Cost of revenue | $17062 | $17135 | $17081 | $15355 |
| Gross Profit | $4884 | $5839 | $6002 | $4421 |
| Operating activities | ||||
| Research & development | $545 | $567 | $569 | $637 |
| Selling, general & administrative | $2879 | $2861 | $2586 | $2827 |
| Total operating expenses | $20728 | $20726 | $20430 | $18137 |
| Operating income | $1218 | $2248 | $2653 | $1639 |
| Income from continuing operations | ||||
| EBIT | $1218 | $2248 | $2653 | $1639 |
| Income tax expense | $287 | $479 | $557 | $245 |
| Interest expense | -$169 | -$145 | -$121 | -$153 |
| Net income | ||||
| Net income | $909 | $2090 | $1221 | $898 |
| Income (for common shares) | $909 | $2090 | $1221 | $898 |
| (in millions $) | 30 Dec 2021 | 30 Dec 2020 | 30 Dec 2019 | 30 Dec 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $78598 | $59149 | $59316 | $60220 |
| Cost of revenue | $59091 | $44383 | $43347 | $43156 |
| Gross Profit | $19507 | $14766 | $15969 | $17064 |
| Operating activities | ||||
| Research & development | $2216 | $2086 | $2158 | $1994 |
| Selling, general & administrative | $9902 | $8835 | $9382 | $9200 |
| Total operating expenses | $71031 | $56048 | $55604 | $54324 |
| Operating income | $7567 | $3101 | $3712 | $5896 |
| Income from continuing operations | ||||
| EBIT | $7567 | $3101 | $3712 | $5896 |
| Income tax expense | $1430 | -$91 | $756 | $1117 |
| Interest expense | -$506 | -$557 | -$673 | -$537 |
| Net income | ||||
| Net income | $5523 | -$1060 | $8421 | $4707 |
| Income (for common shares) | $5523 | -$1060 | $8421 | $4707 |
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Net income | $909 | $2090 | $1221 | $898 |
| Operating activities | ||||
| Depreciation | $973 | $953 | $924 | $904 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $2301 | $1228 | -$290 | $3337 |
| Investing activities | ||||
| Capital expenditures | -$1006 | -$892 | -$603 | -$1490 |
| Investments | $104 | -$117 | $15 | -$615 |
| Total cash flows from investing | -$680 | -$639 | -$579 | -$692 |
| Financing activities | ||||
| Dividends paid | -$16 | -$3071 | ||
| Sale and purchase of stock | ||||
| Net borrowings | -$1938 | $2061 | $3504 | -$2916 |
| Total cash flows from financing | -$2188 | -$1386 | $2685 | -$2967 |
| Effect of exchange rate | $131 | |||
| Change in cash and equivalents | -$567 | -$798 | $1815 | -$199 |
| (in millions $) | 30 Dec 2021 | 30 Dec 2020 | 30 Dec 2019 | 30 Dec 2018 |
|---|---|---|---|---|
| Net income | $5523 | -$1060 | $8421 | $4707 |
| Operating activities | ||||
| Depreciation | $3543 | $3871 | $3732 | $3080 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $7245 | $5413 | $7474 | $7939 |
| Investing activities | ||||
| Capital expenditures | -$3532 | -$3129 | -$3824 | -$3894 |
| Investments | -$994 | -$877 | -$1126 | -$1210 |
| Total cash flows from investing | -$2622 | -$1904 | -$1190 | -$11804 |
| Financing activities | ||||
| Dividends paid | -$3031 | -$3031 | -$2939 | -$2847 |
| Sale and purchase of stock | ||||
| Net borrowings | -$3145 | $1580 | -$3342 | $2966 |
| Total cash flows from financing | -$6457 | -$1556 | -$6405 | -$52 |
| Effect of exchange rate | $131 | -$81 | $37 | -$59 |
| Change in cash and equivalents | -$1711 | $1880 | -$64 | -$3976 |
News
|
Is BASF SE (BAS.DE) The Best Annual Dividend Stock To Buy Now?
Insider Monkey · via Yahoo Finance
10 Feb 2025
|
|
BASF's Personal Care Unit Unveils Innovative Technology for Retinol
Zacks · via Yahoo Finance
24 Jan 2025
|
|
Is BASF SE (BAS.DE) a Good German Dividend Stock to Invest In Now?
Insider Monkey · via Yahoo Finance
29 Dec 2024
|
|
BASF SE Divests Food and Health Performance Ingredients Unit
Zacks · via Yahoo Finance
26 Dec 2024
|
|
BASF (BASFY) and Siemens Unveil Biomass Circuit Breaker
Zacks · via Yahoo Finance
19 Jun 2024
|
|
BASF (BASFY)-Encina Announce Long-Term Recycled Benzene Deal
Zacks · via Yahoo Finance
13 Jun 2024
|
|
BASF (BASFY) to Expand Basoflux Production Capacity in Tarragona
Zacks via Yahoo Finance
16 May 2024
|
|
BASF SE (PNK:BASFY) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance
26 Apr 2024
|
|
Basf SE's Dividend Analysis
GuruFocus.com via Yahoo Finance
25 Apr 2024
|
|
BASF (BASFY) to Feature Sustainable Solutions at CHINAPLAS
Zacks via Yahoo Finance
9 Apr 2024
|
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $87.78B |
|---|---|
| EBITDA | $11.51B |
| EBIT | $7.76B |
| Net Income | $5.12B |
| Revenue Q/Q | 11.58% |
| Revenue Y/Y | 17.47% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | 5.45% |
| ROE | 11.73% |
| Debt/Equity | 1.11 |
|---|---|
| Net debt/EBITDA | 3.89 |
| Current ratio | 1.72 |
| Quick ratio | 1.02 |